For the first time, a drug discovered at UWM approved to begin clinical trials
If compound survives an arduous approval process, it could be used to treat depression, Alzheimer's or schizophrenia. |!| University of Wisconsin--Milwaukee
If compound survives an arduous approval process, it could be used to treat depression, Alzheimer's or schizophrenia. |!| University of Wisconsin--Milwaukee